Press Release: 21st Virtual PCF Pharma & Med Device Ethics & Compliance Congress Features Keynote by OIG Senior Counsel Mary E. Riordan, JD
  • Virtual Online Video Event Live and 6 Months Access to Video Archive
  • Sponsored by the Pharmaceutical Compliance Forum
  • Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
  • November 4 - 6, 2020
  • www.PharmaCongress.com

PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com
SPEAKER PRESENTATION PROPOSALS
Speaker/Presentation Proposals for the Virtual 21st Anniversary Pharma Congress May Be Submitted Through Our Online Form
- Click Here -

EARLY BIRD REGISTRATION DISCOUNTS NOW AVAILABLE
Early bird registration discounts now available with special PCF rates. Rates are up to $1,000 less than major competing events.
- Click here to register.

WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- AUGUST 28, 2020: The 21st Anniversary Pharmaceutical and Medical Device Compliance Congress, www.PharmaCongress.com, to be held November 4 - 6, 2020 as a fully virtual event, today announced the conference dates and a call for presentation proposals.

KEYNOTE ADDRESS BY
Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC

FEATURING THE ANNUAL INVITATION-ONLY CHIEF COMPLAINCE OFFICER ROUNDTABLE
November 4, 2020; Invitation-only; No Cost. CCOs interested in attending may contact Debra Scanlon, Administrator, Pharmaceutical Compliance Forum at info@pharmacomplianceforum.org.
CONGRESS HIGHLIGHTS
  • New content, optimized for online learning, focused on new regulatory developments and managing ethics and compliance programs during the COVID 19 pandemic
  • Engage with faculty through polling, Q&A sessions, chat and direct messaging
  • Network in real time with other attendees through our Slack chat sessions and direct attendee to attendee messaging
  • Live and curated sessions, streamed directly to you through our easy to navigate virtual platform
  • Access to an extensive video archive of past Congress presentations providing a context for the evolution of the compliance professions and the legal and regulatory setting
  • Virtual exhibit hall featuring innovative solutions, products and services with opportunity to directly contact exhibitors for further information

FEATURED FACULTY

Sergio Alegre, JD Vice President, Global Compliance, Osmotica, Former Executive Director Compliance, Pacira, Bridgewater, NJ

Dennis K. Barnes, JD CPA Vice President, Global Governance, Risk & Compliance, Mayne Pharma, Former Vice President, Compliance & Risk Management, Global Compliance Officer, PAREXEL International, Raleigh-Durham, NC

Christie Camelio Chief Compliance, Ethics & Risk Management Officer, TG Therapeutics, Former, Vice President, Deputy Global Chief Compliance Officer, Celgene, New York, NY

Cynthia Cetani Chief Integrity & Compliance Officer, Indivior, Former Group Integrity & Compliance, Head, Compliance Operations, Novartis International AG, Richmond, VA

Katherine Chaurette, MS, JD Vice President Healthcare Law and Compliance, Blueprint Medicines, Former Sr. Director, Regulatory and Commercial Law, Regeneron, Former VP, Legal, Head of Health Law, Regulatory, Market Access, Marketed and Launch Products, Sanofi, Jamaica Plain, MA

Masha Chestukhin, MSJ Associate Director, Compliance Officer R&D, IA, FMV, Sanofi Genzyme, Former Senior Manager NA Compliance, Sanofi, Jamaica Plain, MA

Yvonne Clark, JD Corporate Compliance Counsel, Spark Therapeutics, Former Commercial Counsel, Merck, Philadelphia, PA

Michael R. Clarke, CCEP Vice President, Global Chief Compliance Officer, ConvaTec, Former VP, Corporate Compliance, Indivior, Former VP, Ethics & Compliance, Americas, Actavis, Former VP & Compliance Officer, Biomet Spine & Bone Healing Technologies, Bridgewater, NJ

Margaret Feltz, MA, JD Vice President, Ethics & Compliance, Purdue Pharma, Former Compliance Counsel, Boehringer Ingelheim, Stamford, CT

Betania Glorio, LLM Global Compliance Officer, Healthcare, Merck KGaA, Former Senior Director, Legal and Compliance EMEA, Horizon, Raptor and Onyx, Darmstadt, Germany

Nancy A. Grygiel, JD Senior Vice President, Chief Compliance Officer, Amgen, Former VP Compliance, Corporate & International, Allergan, Former Senior Director Global Compliance, Mylan, Newbury Park, CA

Michael Joachim, JD Head of Ethics & Business Integrity, Specialty Care, Sanofi Genzyme, Cambridge, MA

Ben Kaye-Smith Senior Vice President Ethics, Risk & Compliance, AveXis, Former Corporate Health Safety Environment Manager, Former Global Head Integrity & Compliance Risk Review & Prevention, Novartis, Switzerland

John Knighton, JD Chief Compliance Officer, TherapeuticsMD, Former Vice President, Head of Global Compliance, Orexigen Therapeutics, Boca Raton, FL

Keith Korenchuk, MPH, JD Vice President and Chief Compliance Officer, DH Diagnostics, a Danaher Company, Chevy Chase, MD

Kirt Kraeuter, MGA Senior Director, Corporate Compliance at Moderna, Former European Compliance Director, Otsuka, Former, Executive Director, Worldwide Compliance Committee & Monitoring, Bristol-Myers Squibb, Yardley, PA

Kari Loeser, JD US Healthcare Compliance Officer, Relypsa, Former Senior Counsel, Jazz Pharmaceuticals, Former Senior Manager, Genentech, Redwood City, CA

Joshua Marks, JD Vice President, Chief Ethics & Compliance Officer, Boehringer Ingelheim, Former Executive Division Counsel, Corporate Compliance Officer & Asst. Secretary, Ben Venue Laboratories, Ridgefield, CT

Jane Mathews, LLM, JD Vice President and Chief Compliance Officer, Lexicon, Former Assistant General Counsel, Sunovion, Former Senior Counsel-Managing Attorney - Head of Litigation, Hoffmann-La Roche, Ringwood, NJ

Jenny McVey, MS, PHD Compliance Risk Strategy & Management, Novo Nordisk, Compliance Lead, Hands International, Editorial Board Member, Policy & Medicine Compliance Update, Princeton, NJ

Gregory S. Moss, LLB Executive Vice President, General Counsel and Corporate Secretary, Chief Compliance Officer, Kadmon Holdings, New York, NY

Brad Powers, JD General Counsel and Chief Compliance Officer, Lumos Pharma, Former General Counsel and Chief Compliance Officer, Office of the CEO, NewLink Genetics, Des Moines, IA

Kristin Rand, JD, MA Head, Corporate Compliance and Global Risk Officer, Moderna, Former Vice President & Chief Compliance Officer, Seattle Genetics, Boston, MA

Kevin Ryan, MS, JD Vice President, Chief Compliance Officer, ACADIA, Former Director, Ethics & Compliance, Novo Nordisk, San Diego, CA

Jonathan Sayegh, JD Associate Director, Compliance & Ethics, Sunovion, Marlborough, MA

Eric Siegel, MBA, JD Chief Compliance Officer, Jazz Pharmaceuticals, Former Senior Investigator, Office of the Inspector General, City of Philadelphia, Philadelphia, PA

Latarsha Stewart, MS, JD Head of Compliance, Servier Pharmaceuticals; Former Head of Compliance, Global Oncology Business Unit, Takeda Oncology, Boston, MA

Seth B. Whitelaw, JD, LLM, SJD President and Chief Executive Officer, Whitelaw Compliance Group, LLC, Editor, Life Science Compliance Update, Senior Fellow & Adjunct Professor, Life Sciences Compliance, Mitchell Hamline School of Law, West Chester, PA

Amy Yuda, JD, CHC, CQA, CCEP Compliance Officer, PolarityTE, Salt Lake City, UT

2020-2021 GLOBAL PHARMA/MED DEVICE ETHICS & COMPLIANCE CONGRESSES

VIRTUAL TWENTY-FIRST ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Virtual Online Video Event Live and Archived
Sponsored by Pharmaceutical Compliance Forum
Media Partners: Harvard Health Policy Review, Health Affairs and Policy & Medicine Compliance Update
November 4 – 6, 2020
www.PharmaCongress.com
VIRTUAL FOURTEENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE ETHICS & COMPLIANCE CONGRESS
Virtual Online Video Event Live and Archived
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Media Partner: Policy & Medicine Compliance Update
February 22 – 25, 2021
www.International PharmaCongress.com

SPONSORED BY

The Pharmaceutical Compliance Forum (PCF) is a coalition of compliance professionals including compliance officers and senior legal counsels from 70+ distinguished researched-based pharmaceutical manufacturers and biotech companies. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effect corporate compliance programs.


CO CHAIRS

Indrani Franchini, JD
Executive Vice President Chief Compliance Officer, Alexion Pharmaceuticals, New York, NY
(PCF CO-Chair)


Jeffrey Kawalek, MBA
Deputy Chief Compliance Officer, Jazz Pharmaceuticals, Inc., Philadelphia, PA
(PCF Chair)


Margaret Sparks, JD
Associate Vice President, North America Ethics and Business Integrity, Sanofi US, Bridgewater, NJ (PCF Co-chair)


Ann Marie Tejcek
Senior Director, Chief Compliance Officer North America, Eli Lilly, Indianapolis, IN
(PCF CO-Chair)


Donna White, CCEP
Vice President, Contracts & Compliance Chiesi, Cary, NC
(PCF CO-Chair)


Joe Zimmerman
Vice President and Chief Compliance Officer US, Ferring Pharmaceuticals, Parsippany, NJ
(PCF Co-chair)

MEDIA PARTNERS:






GRANTORS:
GOLD


SILVER




BRONZE


Sponsor of Pharma Congress









STAY CONNECTED


Tweet using #PharmaCongress

PAST GLOBAL PHARMA COMPLIANCE CONGRESSES

2007 - Brussels


2008 - Paris


2009 - Rome

CONGRESS REGISTRATION
For Congress registration information, visit https://www.pharmacongress.com/registration/, email reginfo@hcconferences.com, or call 800-503-7419.

CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
For sponsorship and exhibit information contact Suzanne Tyler, Exhibit Manager, at (206) 244-4861 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.